Clinical Trial Update: Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating maintenance therapy with lenvatinib and pembrolizumab for advanced unresectable pancreatic cancer. The study is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• LENVIMA (lenvatinib)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Advanced Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8 | Phase 2 | Status: RECRUITING